Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats

[1] Adamowicz P(2020)Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography-tandem mass spectrometry J Appl Toxicol 40 1033-1046

[2] Armenian P(2018)Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review Neuropharmacology 134 121-132

[3] Åstrand A(2018)Correlations between metabolism and structural elements of the alicyclic fentanyl analogs cyclopropyl fentanyl, cyclobutyl fentanyl, cyclopentyl fentanyl, cyclohexyl fentanyl and 2,2,3,3-tetramethylcyclopropyl fentanyl studied by human hepatocytes and LC-QTOF-MS Arch Toxicol 93 95-106

[4] Åstrand A(2020)In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—on-target receptor potency and efficacy, and off-target effects Forensic Sci Int 317 169-174

[5] Åstrand A(2020)Activation of the μ-opioid receptor by alicyclic fentanyls: changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure Drug Test Anal 13 995-998

[6] Baumann MH(2018)Pharmacological research as a key component in mitigating the opioid overdose crisis Trends Pharmacol Sci 39 738-748

[7] Bergh MS(2019)Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male rats Neuropharmacology 158 519-527

[8] Bergh MS(2018)Addressing the fentanyl analogue epidemic by multiplex UHPLC-MS/MS analysis of whole blood Ther Drug Monit 40 e7-e8

[9] Bergh MS(2019)Distinguishing between cyclopropylfentanyl and crotonylfentanyl by methods commonly available in the forensic laboratory Ther Drug Monit 41 80-85

[10] Brede WR(2019)A wolf in sheep’s clothing J Anal Toxicol 43 193-199

[1] Adamowicz P(2020)Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography-tandem mass spectrometry J Appl Toxicol 40 1033-1046

[2] Armenian P(2018)Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review Neuropharmacology 134 121-132

[3] Åstrand A(2018)Correlations between metabolism and structural elements of the alicyclic fentanyl analogs cyclopropyl fentanyl, cyclobutyl fentanyl, cyclopentyl fentanyl, cyclohexyl fentanyl and 2,2,3,3-tetramethylcyclopropyl fentanyl studied by human hepatocytes and LC-QTOF-MS Arch Toxicol 93 95-106

[4] Åstrand A(2020)In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—on-target receptor potency and efficacy, and off-target effects Forensic Sci Int 317 169-174

[5] Åstrand A(2020)Activation of the μ-opioid receptor by alicyclic fentanyls: changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure Drug Test Anal 13 995-998

[6] Baumann MH(2018)Pharmacological research as a key component in mitigating the opioid overdose crisis Trends Pharmacol Sci 39 738-748

[7] Bergh MS(2019)Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male rats Neuropharmacology 158 519-527

[8] Bergh MS(2018)Addressing the fentanyl analogue epidemic by multiplex UHPLC-MS/MS analysis of whole blood Ther Drug Monit 40 e7-e8

[9] Bergh MS(2019)Distinguishing between cyclopropylfentanyl and crotonylfentanyl by methods commonly available in the forensic laboratory Ther Drug Monit 41 80-85

[10] Brede WR(2019)A wolf in sheep’s clothing J Anal Toxicol 43 193-199